GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CV Sciences Inc (OTCPK:CVSI) » Definitions » Shiller PE Ratio

CV Sciences (CV Sciences) Shiller PE Ratio : (As of Jun. 07, 2024)


View and export this data going back to 2011. Start your Free Trial

What is CV Sciences Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


CV Sciences Shiller PE Ratio Historical Data

The historical data trend for CV Sciences's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CV Sciences Shiller PE Ratio Chart

CV Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CV Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CV Sciences's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, CV Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CV Sciences's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CV Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where CV Sciences's Shiller PE Ratio falls into.



CV Sciences Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

CV Sciences's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, CV Sciences's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.004/131.7762*131.7762
=-0.004

Current CPI (Mar. 2024) = 131.7762.

CV Sciences Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.240 100.560 0.315
201409 -0.010 100.428 -0.013
201412 -0.280 99.070 -0.372
201503 -0.080 99.621 -0.106
201506 -0.060 100.684 -0.079
201509 -0.030 100.392 -0.039
201512 -0.190 99.792 -0.251
201603 -0.030 100.470 -0.039
201606 -0.040 101.688 -0.052
201609 -0.040 101.861 -0.052
201612 -0.160 101.863 -0.207
201703 -0.060 102.862 -0.077
201706 -0.010 103.349 -0.013
201709 -0.010 104.136 -0.013
201712 0.010 104.011 0.013
201803 0.010 105.290 0.013
201806 0.030 106.317 0.037
201809 0.030 106.507 0.037
201812 0.030 105.998 0.037
201903 -0.100 107.251 -0.123
201906 0.010 108.070 0.012
201909 -0.020 108.329 -0.024
201912 -0.070 108.420 -0.085
202003 -0.050 108.902 -0.061
202006 -0.050 108.767 -0.061
202009 -0.030 109.815 -0.036
202012 -0.090 109.897 -0.108
202103 -0.030 111.754 -0.035
202106 -0.030 114.631 -0.034
202109 0.000 115.734 0.000
202112 -0.080 117.630 -0.090
202203 -0.020 121.301 -0.022
202206 -0.030 125.017 -0.032
202209 -0.010 125.227 -0.011
202212 -0.020 125.222 -0.021
202303 0.040 127.348 0.041
202306 -0.010 128.729 -0.010
202309 -0.003 129.860 -0.003
202312 -0.010 129.419 -0.010
202403 -0.004 131.776 -0.004

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CV Sciences  (OTCPK:CVSI) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


CV Sciences Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of CV Sciences's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CV Sciences (CV Sciences) Business Description

Traded in Other Exchanges
Address
9530 Padgett Street, Suite 107, San Diego, CA, USA, 92126
CV Sciences Inc is a consumer wellness company specializing in hemp extracts and other proven, science-backed, natural ingredients and products, which are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). The company also operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based novel therapeutics.
Executives
William Mccorkle director 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Corroon James Michael Jr. director 9530 PADGETT STREET, SUITE 107, SAN DIEGO CA 92126
Maroon Joseph C Md director 2688 S. RAINBOW BLVD., SUITE B, LAS VEGAS NV 89146
Mona Michael Joseph Jr director 2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Paul Blake director 145 BRANDYWINE PKWY, WEST CHESTER PA 19380
Douglas Jesse Mackay officer: Sr VP Scientific/Regulatory 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Joseph D Dowling officer: Chief Financial Officer 2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Joerg Grasser officer: CFO 2688 SOUTH RAINBOW BLVD STE B, LAS VEGAS NV 89146
Elizabeth Ann Altman director 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Terri F Graham director C/O JACK IN THE BOX INC, 9330 BALVOA AVE, SAN DIEGO CA 92123
Stephen Martin Schmitz director 2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
Gary Sligar director 2688 SOUTH RAINBOW BOULEVARD, SUITE B, LAS VEGAS NV 89146
James A Mcnulty director C/O CV SCIENCES, INC., 2688 S. RAINBOW BLVD., SUITE B, LAS VEGAS NV 89146
Larry Phillip Raskin director 1630 FUNNY CIDE DRIVE, WAXHAW NC 28173
Mackay Ventures Inc. other: Member 10% holding group 6325 S. JONES BOULEVARD #500, LAS VEGAS NV 89118

CV Sciences (CV Sciences) Headlines